Related Experiment Video
Updated: Jul 13, 2026
11:01
Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
Visual object recognition in early Alzheimer's disease: deficits in semantic processing
S Laatu1, A Revonsuo, H Jäykkä
1Centre for Cognitive Neuroscience, University of Turku, Finland. sari.laatu@utu.fi
Acta Neurologica Scandinavica
|July 16, 2003
Summary
Early Alzheimer's disease (AD) impairs visual object recognition, particularly semantic processing stages. This study highlights how semantic memory deficits affect daily life for AD patients.
Area of Science:
- Neuroscience
- Cognitive Psychology
Background:
- Visual object recognition is a complex process involving multiple stages.
- Early Alzheimer's disease (AD) is known to affect cognitive functions, but specific impacts on object recognition are not fully elucidated.
Purpose of the Study:
- To delineate the stages of visual object recognition.
- To identify which specific stages are compromised in the early stages of Alzheimer's disease.
Main Methods:
- Utilized two-choice reaction-time tasks to assess performance.
- Evaluated object detection, familiarity detection, semantic categorization, and identification with naming.
- Compared 10 newly diagnosed Alzheimer's disease patients with 14 healthy controls.
Main Results:
- Patients with early Alzheimer's disease demonstrated impairments across multiple object recognition stages.
- After accounting for visuomotor slowness, object detection performance was comparable to controls.
- Significant difficulties were observed in all stages requiring semantic processing.
Conclusions:
- Semantic memory impairments are a key contributor to visual object recognition deficits in early Alzheimer's disease.
- These semantic deficits can manifest in various everyday difficulties experienced by Alzheimer's patients.
More Related Videos
06:48Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment
Published on: June 25, 2019
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:12Visual Agnosia
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round end"...
01:24Prosopagnosia
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...